
==== Front
Biomed Rep
Biomed Rep
BR
Biomedical Reports
2049-9434
2049-9442
D.A. Spandidos

BR-21-5-01849
10.3892/br.2024.1849
Review
Advances in antibacterial activity of zinc oxide nanoparticles against Staphylococcus aureus (Review)
Hao Yuqing 1
Wang Yadong 2
Zhang Li 3
Liu Fang 1
Jin Yuefei 1
Long Jinzhao 1
Chen Shuaiyin 1
Duan Guangcai 1
Yang Haiyan 1
1 Department of Epidemiology, College of Public Health, Zhengzhou University, Zhengzhou, Henan 450001, P.R. China
2 Department of Toxicology, Henan Center for Disease Control and Prevention, Zhengzhou, Henan 450016, P.R. China
3 Department of Infectious diseases, Xinyang Center for Disease Control and Prevention, Xinyang, Henan 464000, P.R. China
Correspondence to: Professor Haiyan Yang, Department of Epidemiology, College of Public Health, Zhengzhou University, 100 Science Avenue, Zhengzhou, Henan 450001, P.R. China schreiner.oliver-daniel@email.umfiasi.ro yhy@zzu.edu.cn
11 2024
30 8 2024
30 8 2024
21 5 16116 4 2024
06 8 2024
Copyright: © 2024 Hao et al.
2024
https://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
Nanoparticles (NPs) are one of the promising strategies to deal with bacterial infections. As the main subset of NPs, metal and metal oxide NPs show destructive power against bacteria by releasing metal ions, direct contact of cell membranes and antibiotic delivery. Recently, a number of researchers have focused on the antibacterial activity of zinc oxide nanoparticles (ZnO NPs) against Staphylococcus aureus (S. aureus). Currently, there is a lack of a comprehensive review on ZnO NPs against S. aureus. Therefore, in this review, the antibacterial activity against S. aureus of ZnO NPs made by various synthetic methods was summarized, particularly the green synthetic ZnO NPs. The synergistic antibacterial effect against S. aureus of ZnO NPs with antibiotics was also summarized. Furthermore, the present review also emphasized the enhanced activities against S. aureus of ZnO nanocomposites, nano-hybrids and functional ZnO NPs.

zinc oxide nanoparticles
Staphylococcus aureus
antibacterial activity
Funding: The present study was supported by grants from the National Natural Science Foundation of China (grant number 82273696 and 81973105). The funders have no role in the preparation of manuscript and decision to submission.
==== Body
pmc1. Introduction

Staphylococcus aureus (S. aureus) is a gram-positive pathogen that can lead to numerous infectious diseases, such as pneumonia, endocarditis, osteomyelitis, skin and soft tissue infections, bacteremia and sepsis (1). At the same time, the threat caused by S. aureus infections has increased significantly in humans as well as in animals (2,3). In clinical practices, antibiotics are effective way to treat S. aureus infections. With the use of antibiotics (especially overuse or misuse of antibiotics), antibiotic resistant S. aureus strains, such as methicillin-resistant S. aureus (MRSA), have spread both in hospitals and communities and also persist in the home environment, which poses a great threat to human health (4,5). It is estimated that 700,000 persons succumb to antibiotic-resistance bacteria including MRSA and this number is predicted to grow to 10 million by 2050(3). In order to deal with this, increasing efforts have been made to discover new therapeutic strategies to fight against S. aureus infections, such as bacteriophage (6,7), vaccines (8-10), monoclonal antibodies (11,12), recombinant endolysins (13), anti-persistent bacteria therapies (14), antibacterial peptide (15,16), natural plant components (17-19) and nanoparticles (NPs) (20,21).

NPs, being <100 nm, are one of the novel promising methods to deal with bacterial infections, including S. aureus infections (22,23). The antibacterial activity of NPs is mostly attributed to their special characteristics, such as well-distributed size, perfect spherical shape, positive surface charge and hydrophobicity (24,25). NPs begin their antibacterial effects by the direct interplay with cell surface, involving the destruction of cell wall peptidoglycan and membrane protein and interference in energy metabolism (ATPase inhibition and electron transport disruption). Then, NPs can penetrate into cytoplasm and cause great damage to intracellular components, including nucleic acids, proteins, lysosomes and ribosomes (26). Additionally, oxidative stress induced by excess releasing of reactive oxygen species (ROS) also plays a substantial role in inducing lipid peroxidation on the bacterial cell membrane (27). As well as the aforementioned mechanism, metal NPs have specific ways to resist pathogenic microorganisms by releasing metal ions and producing different ROS (28). Several metal (gold, silver, copper and zinc) NPs and their metal oxide NPs have been reported to have distinctive antimicrobial properties against S. aureus (29,30) and they were also shown to be the carriers that can deliver antibiotics to target sites (22,31). Fig. 1 shows the properties, antibacterial mechanism against S. aureus and antibiotics delivery ability of zinc oxide nanoparticles (ZnO NPs).

There are a number of studies reporting the antibacterial property of ZnO NPs against S. aureus (32-34). ZnO NPs reduce the biofilm of S. aureus by inhibiting biofilm genes expression, such as ica A, ica D and fnb A (35). In Kahandal et al (36), the biofilm formation of S. aureus was inhibited markedly by 95.39 % when treated with 125 µg/ml of ZnO NPs for 5 h. Abdelraheem et al (37) observed that ZnO NPs presented antibacterial activity against multidrug resistant S. aureus, such as methicillin, vancomycin and linezolid resistant S. aureus. Irfan et al (38) confirmed the antibacterial activity of ZnO NPs against S. aureus and MRSA with the zone of inhibition (ZOI) of 21±2 and 17±2 mm, respectively. El-Masry et al (39) also reported that ZnO NPs (20 nm and concentration of 20 mM) inhibited 105 and 107 CFU/ml S. aureus with ZOI of 26 and 22 mm, respectively. Currently, there is a lack of a comprehensive review on ZnO NPs against S. aureus. Therefore, the present study reviewed the antibacterial activity against S. aureus of ZnO NPs fabricated by various synthetic ways, especially the green synthetic ZnO NPs. It also summarized the synergistic antibacterial effects against S. aureus of ZnO NPs in combination with antibiotics. Furthermore, it highlighted the enhanced activities against S. aureus of ZnO nanocomposites, nano-hybrids and functional ZnO NPs.

2. Chemically and physically synthesized ZnO NPs against S. aureus

Commonly, ZnO NPs can be synthesized by using top-down and bottom-up methods that include diverse physical and chemical ways (40) (Fig. 2). Top-down approaches cut massive materials into NPs physically, including ball milling, ion sputtering, laser ablation, metal etching and pyrolysis. According to Massoudi et al (41) research, ZnO NPs made by high-speed ball milling inhibit S. aureus with the largest ZOI of ~13.5±0.5 mm. It was also found that ZnO NPs synthesized by microwave heating displayed the ZOI of ~16 mm against S. aureus (42). Bottom-up ways fabricated atoms and molecules into nano-sized particles, which included chemical reduction, sol-gel method, chemical vapor deposition, molecular condensation and even green synthesis (43). Different synthesis processes bring about various physicochemical properties of metal NPs such as size, shape, dispersity and stabilization diversity, which determine the antibacterial efficiency (44,45). Table I shows the characteristics and anti-S. aureus capacity of ZnO NPs made by several methods. In Bai et al (46), small molecule ligand solvothermal synthesized ZnO NPs showed size-related antibacterial effect and the minimum inhibitory concentration (MIC) of 4 nm ZnO NPs against S. aureus was 6.25 µg/ml, which is lower than the MIC of 10 nm ZnO NPs at ~25 µg/ml. In an antimicrobial test of solution-polymerization-method synthesized ZnO NPs, it was discovered that S. aureus was more susceptible to nanoparticle size than E. coli (47). The co-precipitation method is also frequently used to synthesize ZnO NPs that show the lowest MIC against S. aureus compared with other bacteria (48). Moreover, by using an easy chemical method, diethylene-glycol-mediated ZnO NPs were made and they had antibacterial activity against S. aureus with the ZOI of 14 mm and showed the excellent S. aureus biofilm control (49). It was also reported that S. aureus cell leakage was observed after exposure to mechano-chemical synthesized ZnO NPs (50). Although a great number of physicochemical synthetic methods have been found to make ZnO NPs for S. aureus treatment, some demerits such as high cost, toxicity and instability still place restrictions on their large-scale antibacterial applications (43).

3. Green-synthesized ZnO NPs against S. aureus

Recently, green biological materials drew much attention to researchers for their environment-friendly, cost-effective, low-toxicity and useful properties to make ZnO NPs (26). There are a number of types of biological materials such as bacteria, fungi, algae and plant extracts (51,52) (Fig. 3), which serve as reducing agents, capping agents, stabilizers and ligands during the synthesis of ZnO NPs (26) and their effects are ion reduction, size and shape control, NPs surface stabilization, metal passivation and coating, respectively, which are important to the antimicrobial properties of ZnO NPs (26,53). The antibacterial properties of green-synthesized ZnO NPs against S. aureus are in Table II.

Plant extracts synthesis

Due to different synthetic raw materials, plant-derived ZnO NPs are provided with multifarious characteristics. Triangle-like M-ZnO-NPs and B-ZnO-NPs were made by Mentha spicata and Ocimum basilicum acting as capping, stabilizing and reducing agents with size of 24.5 and 26.7 nm, respectively. These types of ZnO NPs had antibacterial properties against S. aureus (ATCC 25923) with a 14.73 mm ZOI with 0.01 g/ml M-ZnO-NPs (54). In Sachin et al (55), ZnO NPs synthesized by using lychee peel extract were spherical and small (<10 nm) and were also proved to combat S. aureus (ATCC25923) with 15 mm ZOI of 100 µg/ml ZnO NPs. In Mohammed et al (56), zinc nitrate hexahydrate and Cymbopogon citratus extracts were used to synthesize ZnO NPs, which killed S. aureus cells with a MIC of 88.13±0.35 µg/ml. In Mushtaq et al (57), methanol and water leaf extracts of Viscum album were applied to fabricate ZnO NPs that were quasi-spherical with size of 13.5 nm and which showed considerable inhibitory effects against S. aureus with a ZOI of 39±0.3 and 40±0.3 mm, respectively. Due to having a higher content of DNA gyrase-B inhibitor, the water extracts of ZnO NPs were proved to be more effective in limiting bacterial growth. ZnO NPs with flower-shaped structures were created by a green nanotechnology facility in Hasan et al (58) and showed 90.9% inhibition against S. aureus. It is noteworthy that the ZnO NPs showed more durable antimicrobial activity than Ag NPs in in vivo tests, which may be attributed to their distinctive morphology and massive active surface sites. In Irfan et al (59), green-synthesized ZnO NPs by Gum Acacia modesta expressed antimicrobial ability against MRSA with a ZOI of 16±2 mm. Alallam et al (60) also observed that ZnO NPs made by pure curcumin had a great ability to combat MRSA. Notably, these green-synthesized ZnO NPs showed a minimal cytotoxicity compared with chemically synthesized ZnO NPs (61). Furthermore, in Ting et al (53), ZnO NPs biosynthesized by using the aqueous extract of Andrographis paniculata leaves demonstrated a high inhibition on S. aureus and then controlled periimplantitis. ZnO NPs synthesized by using ethanolic extracts of Eupatorium odoratum are reported to show more than 97% biofilm inhibition of S. aureus that could be applied to reduce central venous catheter associated infections (61).

Algae synthesis

Algae are known as ‘bio-nano-factories’ due to their various properties, such as low risk of environmental toxicity, simple processing methods and the ability to redox metals (62). In addition, algal extracts are full of bioactive molecules that can be used as reducing and stabilizing agents. The biosynthesis of ZnO NPs using microalgae was authenticated to be a cost-effective method and the ZAA2 strain microalgae-synthesized ZnO NPs showed outstanding antibacterial activity with the largest ZOI of ~20 mm against S. aureus (63). In addition, by using Chlorella vulgaris as green resource, biogenic ZnO NPs were produced having significant antibacterial activity against MRSA, attributed to their excellent size distribution and surface energy (64). Researchers have also investigated the phyco-synthesis of UFD-ZnO NPs using extract of Ulva fasciata Delile. The destructive power of UFD-ZnO NPs against S. aureus (ATCC 25923) was time-dependent, while the MIC and ZOI were recorded at ~17.5 µg/ml and 24.9±1.5 mm, respectively (65). In a recent study, Sargassum extracts have been used to synthesize ZnO NPs and the ultrasound-assisted green synthesized ZnO NPs showed the highest inhibition against S. aureus by 99% compared with ZnO NPs alone (66). As one of the phototrophic bacteria, cyanobacteria are the source of bioactive compounds as well as the raw material of ZnO NPs synthesis. By using cell extract of a new cyanobacterial strain Desertifilum sp. EAZ03, ZnO NPs have been made that possess considerable antibiofilm and antimicrobial effects against S. aureus (ATCC 59223) with an MIC value of 32 µg/ml and the minimum bactericidal concentration value of 64 µg/ml (67). Similarly, Ebadi et al (68) synthesized ZnO NPs using the cell extract of the cyanobacterium Nostoc sp. EA03, which were also discovered to destroy S. aureus biofilms and had low cytotoxicity on lung fibroblast cells.

Bacterial synthesis

With their lower purification cost and higher productivity compared with other microorganisms, bacteria are also considered as the raw materials to create ZnO NPs (69,70). According to a biosynthesis test of Yusof et al (71), Lactobacillus plantarum TA4, a microorganism isolated from fermented food, was proved to synthesize ZnO NPs with concentration- and shape-dependent antibacterial capacity. In addition, cell-free supernatant (CFS) and cell-biomass (CB) taken from L. plantarum TA4 were used as reducing agents to synthesize ZnO NPs, respectively. Although the MIC value to inhibit S. aureus of ZnO NPs-CB was lower compared with ZnO NPs-CFS, ZnO NPs were more conveniently purified by CFS (71). From this, it is indispensable to weigh up the pros and cons of different synthetic materials in order to choose the optimal raw material under different demands and experimental environments. In Rehman et al (72), Bacillus haynesii isolated from date palm plant was employed as the reducing agent to establish an eco-friendly nanobiofactory. ZnO NPs mediated by Bacillus cereus showed a spherical shape with median size of 50±5 nm, which damaged S. aureus cell surface by direct contact (72). Streptomyces purified from waste soil can be used to biosynthesize ZnO NPs and the antibacterial effects were identified to combat multiple isolates of S. aureus (73). Taran et al (74) explored the optimum condition to biosynthesize ZnO NPs by using Halomonas elongata IBRC-M 10214 through the Taguchi method (75). Results showed that these ZnO NPs were stable, pure and nontoxic, able to fight against multi-drug resistant bacteria such as S. aureus ATCC 43300. Strain C2 isolated from the genus Leuconostoc of lactic acid bacteria has been employed to biosynthesize metal NPs, including ZnO NPs and Au NPs. According to Kang et al (76), the C2-ZnO NPs expressed a lower MIC value of 512 µg/ml compared with C2-Au NPs (MIC: 1024 µg/ml) against S. aureus.

Fungal synthesis

A number of studies have reported that fungi can be used for synthesizing ZnO NPs. Sharma et al (77) used Phanerochaete chrysosporium to make ZnO NPs with advantages in terms of stability, simple processing, antimicrobial activity and non-cytotoxicity. Mohamed et al (78) produced fungal-synthesized ZnO NPs of 9-35 nm by using Penicillium chrysogenum and found that the ZnO NPs had antibacterial and antibiofilm activities against S. aureus. ZnO NPs synthesized by a simple, non-toxic method using fungal filtrate of Xylaria acuta were promising antimicrobial agents that exhibited an MIC value of 15.6 µg/ml against S. aureus (79). Abdelkader et al (80) synthesized ZnO NPs using Aspergillus niger Endophytic fungal extract with characteristics of stability and antibiofilm activity. It was demonstrated that ZnO NPs reduced the number of biofilm-forming S. aureus from 50-20.83% and the MIC of ZnO NPs against multiple S. aureus strains ranged from 8-128 µg/ml (80). In Motazedi et al (81), the extracellular extract of Saccharomyces cerevisiae was used to create spherical ZnO NPs with dose-dependent antibacterial ability against S. aureus.

4. ZnO NPs cooperating with antibiotics for S. aureus treatment

At present, one of the most serious issues of global health must be antibiotics resistance. The synergy between antibiotics and ZnO NPs attracts much attention and would be a practicable treatment against multi-drug resistant bacteria (82,83). It has been found that ciprofloxacin in conjunction with ZnO@Glu-TSC (thiosemicarbazide-conjugated and glutamic acid-functionalized ZnO NPs) could significantly inhibit the expression of efflux pump genes, which is a vital factor towards antibiotics resistance (84). In addition, ZnO NPs can be excellent drug carriers to target antibacterial agents to the action sites and still achieve desired therapeutic effects for a decreased drug dosage, thus enhancing the antimicrobial efficacy (22). In Habib et al (85), using ZnO NPs combined with ciprofloxacin and imipenem, the ZOI of S. aureus was 17 mm higher than that of E. coli (12 mm). By using ZnO NPs in conjunction with antibiotics to defeat S. aureus, the MICs of six clinical common antibiotics were reduced, which reflected an effective antibacterial cooperation. Furthermore, the anti-biofilm efficacy was also investigated and was enhanced from 34-37% (antibiotics alone) to 65-85% (antibiotics and ZnO NPs combination) (86).

Hemmati et al (87) synthesized and characterized the chitosan-ZnO nanocomposites loading with gentamicin, which caused MIC reduction by four-fold and biofilm reduction by 77% in S. aureus by contrast with the gentamicin alone. Notably, drug-loaded ZnO NPs were shown to exhibit negligible toxicity to human cells (82). Thus, the synergy of ZnO NPs and antibiotics can be applied to a variety of antibacterial circumstances. In an infection model of rats, azithromycin-loaded ZnO NPs displayed enhanced ability to clear MRSA (88). Phytomolecules-coated ZnO NPs combined with tobramycin and gallic acid were synthesized and shown to be an excellent material for contact lenses, expressing a maximum log10 reduction of 5.7±0.02 CFU/ml in the growth of S. aureus and contributed to disruption of bacterial cell wall and membrane, leading to the leakage of cytoplasm and bacterial death (89). These drug-hybrid NPs such as cefazolin-hybrid ZnO NPs are also used to post-operative antimicrobial therapy due to their inhibitory actions against S. aureus both in vitro and in vivo (90).

5. ZnO nanocomposites/hybrids against S. aureus

Non-metal ZnO nano-composites/hybrids against S. aureus

In order to improve the antibacterial activity of ZnO NPs, various non-metal substances have been used to prepare ZnO nanocomposites. In Oves et al (91), the combination of graphene, curcumin and ZnO NPs showed enhanced inhibition against S. aureus more than five-fold compared with graphene-ZnO NPs and the ZnO nanocomposites also suppressed MRSA (ATCC 43300) effectively. Zhai et al (92) designed ZnO-graphene nanocomposites that could enhance rapid antibiosis due to the separation of ZnO electron-hole pairs and increased active sites by transforming the shape of ZnO. Silica nanorattles (SNs) combined with ZnO NPs were reported to exhibit an improved antibacterial activity against MRSA with a lower MIC of 6.25 µg/ml compared with free ZnO NPs in vitro and in vivo. Since the SNs surface protected and amassed the ZnO NPs, the free radicals offered by ZnO NPs had an enhanced efficacy in combating MRSA (93). Vinotha et al (94) developed the Btp-Ac-ZnO nanocomposites by using Acorus calamus extract and bacterial toxic protein (Cry) and they demonstrated the concentration-dependent biofilm inhibition of the synthesized nanocomposites against S. aureus (MTCC 9542). ZnO NPs can also be supported by 4A zeolite, controlling the release of ZnO NPs and enhancing the antibacterial properties (95). It has been shown that pancreatin-doped ZnO nanocomposites have improved performances, such as low-toxicity to human cells and anti-biofilm and anti-motility abilities against MRSA and increased sensitivity for vancomycin against MRSA (96). Canales et al (97) demonstrated that the electrospun scaffolds based on poly (lactic acid), bioglass and ZnO NPs showed biocidal properties against S. aureus with bacteria decreasing by 30%, which may be useful for tissue engineering. Hydroxypropyl methylcellulose film combined with ZnO NPs and carboxymethyl starch have been shown to have excellent antibacterial ability against S. aureus and no toxicity to human HaCat cells and so can be used for wound dressing (98). Majeed et al (99) found that ZnO NPs doped with selenium showed strong inhibition to MRSA, however, teratogenicity was also revealed, which means that it is important to use them cautiously.

Nano-hybrids are also recommended as a good replacement for conventional antibacterial ZnO NPs and have enhanced antibacterial efficacy and low-toxicity on normal cells (100). According to Karthikeyan et al (101), in order to develop nanomaterials with high antibacterial ability compared with antibiotics, the alginate-ZnO hybrid nanomaterials have been synthesized with good inhibition effects on MRSA and low cytotoxicity to human cells. Kang et al (102) reported that the dispersibility of ZnO could be improved by the hybridization of ZnO NPs with nanocellulose and increasing bacterial inhibition rates were shown in S. aureus. Furthermore, in the research of AbouAitah et al (103), a hybrid nano-formulation was developed from ZnO NPs and protocatechuic acid and offered a sustained-release antibacterial effect toward S. aureus (Fig. 4).

Metal-doped ZnO nanocomposites against S. aureus

The activities of metal ions can be improved by the amalgamation of metal NPs. For instance, the release of more zinc and copper ions has been confirmed by ICP-OES analysis in Cu-doped ZnO nanocomposites, which caused enhanced antibacterial activity against S. aureus (104). In Rao et al (105), Na-doped ZnO NPs expressed enhanced inhibition activity against S. aureus with Na-concentration dependence. By using a scaled-up green strategy, cellulose-based Ag-ZnO nanocomposites (AZC) were prepared, which demonstrated good stability. It was also reported that the AZC films showed greater inhibition against S. aureus than E. coli (106). Hu et al (107) revealed that ZnO/Ag bimetallic nanocomposites showed significant inhibition against S. aureus compared with single metal nanomaterials and the cytotoxicity to fibroblasts was reduced by a ZnO and Ag complex. Mohammadi-Aloucheh et al (108) reported that ZnO/CuO nanocomposites synthesized using fruit extracts could lead to the disruption of bacterial membranes and enhanced anti-bacterial ability compared with ZnO NPs alone. Bahari et al (109) synthesized Fe3O4/ZnO nanocomposite by the sol-gel method and the molar ratio of 1:10 showed the best antimicrobial performance against S. aureus with a ZOI of 11.5±0.7 mm. AlSalhi et al (110) used the co-precipitation technique to make magnetic ZnO/ZnFe2O4 nanohybrids that were good photocatalytic material and it was discovered that the membrane of S. aureus collapsed after exposure to the nanohybrids. Lee et al (111) made a multi-metal oxide nanocomposite including ZrO, ZnO and TiO2. It was observed that these nanocomposites demonstrated a killing efficiency of 72.4% against S. aureus. Poly (vinyl alcohol)-based compositions were developed with addition of silver, copper and ZnO NPs, which had the feature of solidifying to be peeled off along with the impaired bacterial film, thereby decreasing the number of S. aureus (112).

6. Functional ZnO NPs for S. aureus treatment

In order to optimize the performance of ZnO NPs to combat pathogenic microorganisms, researchers have given attention to functionalized, modified or capped ZnO NPs (34,113). Choi et al (114) created novel ZnO NPs functionalized with caffeic acid, which expressed enhanced antibacterial efficiency against S. aureus and three MRSA strains. The amino-functionalized hydrophilic ZnO NPs induced the destruction of respiratory electron transformation, generation of intracellular ROS and depolarization of cell membrane in S. aureus (115). Charoensri et al (116) prepared polyaniline-functionalized ZnO NPs by a simple impregnation method; not only did the synthesized ZnO NPs films show enhanced water hydrophobicity, but also expressed increased antibacterial ability against S. aureus, which will make it possible to develop antibacterial biodegradable materials. Lee et al (117) prepared gallic acid functionalized ZnO NPs that had high bacterial cell membrane affinity and showed enhanced bactericidal activity against S. aureus and higher selective inhibition to MRSA strains compared with non-functionalized ZnO NPs. According to Chen et al (118), photosensitizers-functionalized ZnO NPs demonstrated marked S. aureus inhibition and showed low-toxicity on endothelial cells and erythrocyte. In Yuan et al (119), lysozyme-modified ZnO NPs expressed excellent antibacterial activity against S. aureus and MRSA due to their small size, membrane permeability and enzyme-mediated ROS generation and even had lower cytotoxicity than gentamycin at the same concentration.

7. Conclusion and perspectives

In the present study, ZnO NPs synthesized by different methods and their antibacterial activity against S. aureus have been summarized. Taken together, the anti-S. aureus efficacy of ZnO NPs mainly relies on their basic characteristics, especially size and shape. Spherical shape and small size are ideal features of ZnO NPs to combat bacteria that lead to high specific surface areas and more chances to contact with pathogens. In Babayevska et al (24), ZnO NPs with the highest specific surface area showed the size <10 nm. It is also reported that spherical ZnO NPs had the minimal size (31 nm) and higher anti-S. aureus activity (6-7 log CFU ml−1 reduction) compared with flower-shaped particles (3-4 log CFU ml−1 reduction for S. aureus) (44). The detail of ZnO NPs synthesized by various physical and chemical methods has been the subject of recent research (40). Some studies also revealed that these traditional synthesized methods had various shortcomings, such as being environment-contaminating, expensive and energy-intensive (43,120,121). Green synthesis has been emphasized due of its environment-friendly, easy-acquired and low-toxicity features. Some studies also noted that these green materials had antibacterial abilities already, such as mint (122), aloe (123) and curcumin (124), and they endow ZnO NPs with enhanced and steady antibacterial activity against S. aureus (125). Physical or chemical processes are the indispensable part in NPs synthesis. However, ZnO NPs made only by physicochemical ways are cannot compare with biogenic, functional or compound ZnO NPs when they are further applied to clinical antibacterial situations.

ZnO NPs can be used in a number of pre-clinical and clinical antimicrobial fields, including surgical operation (59), post-operative anti-bacterial therapy (90), anti-inflammatory (80) and ophthalmic treatment (126). For example, suture coated by green synthetic ZnO NPs demonstrated excellent tensile strength and wound healing ability in an incision wound rat model (59). An infection model in mice showed that ZnO NPs originating from fungi could significantly decrease hepatic inflammatory markers, restrain congestion and fibrosis in tissues and improve liver function (80). Sindelo et al (127) made the phthalocyanines link to the amino-functionalized ZnO NPs and these nanocomposites showed considerable activities of photodynamic antimicrobial chemotherapy and multi-microbial biofilms eradication. Considering that ZnO NPs had an excellent antibacterial activity against S. aureus and good biocompatibility, a chitosan-ZnO/selenium nanoparticles scaffold was developed to be used for infected wound healing and postoperative treatment of pediatric fractures (128). Ismail et al (129) also reported that ZnO NPs could be used as the hand sanitation in the future, which present improved anti-MRSA activity compared with the commonly used alcohol sanitation.

As one of the primary metal oxide NPs, ZnO NPs express excellent ability against S. aureus, but they still have drawbacks to be widely used as antibiotics replacements in clinical contexts. A few trials in vivo suggested that different metal oxide NPs damage cells to different degrees (45). Venkatraman et al (130) noted the toxicity of ZnO NPs to RAW264 macrophage cells, with half maximal inhibitory concentration (IC50) of 494 µg/ml. Although electrospun scaffolds based on ZnO NPs showed increasing antibacterial activity, it is also reported that cytotoxicity was related to high ZnO content (97). According to Pereira et al (131), erythrocyte changes were also discovered in reptile exposure to ZnO NPs at the dose of 440 µg/kg. Yang et al (132) reported that ZnO NPs could induce apoptosis of mouse-derived spermatogonia cell line GC-1 spg cells. In Al-Zahaby et al (133), ZnO NPs (0.69 mg/l) mediated ROS that induced cell apoptosis and caused sensory toxicity effect on zebrafish olfactory organs. ZnO NPs synthesized by Calotropis procera leaf extract were reported to exhibit potent antimicrobial ability with concentration-dependent manner. However, with increasing exposure to ZnO NPs, deleterious changes (degeneration, swelling and atrophy) were found in the kidney by histology (85). Nazir et al (134) also discovered liver dysfunction in mice intraperitoneal injection groups at ZnO NPs doses of 50 and 100 mg/kg. ZnO NPs were also cytotoxic to the human immune system at doses of 25 and 12 mg/l (135). Despite ZnO NPs exhibiting outstanding capability in inhibiting MRSA, the resistance to NPs by microbes remained. If the dosage of NPs is below the sublethal concentrations, a series of resistance mechanisms would be initiated stealthily by bacteria, resembling their antibiotic resistance (136).

ZnO NPs still have potential toxicity when they are applied to clinical antibacterial treatment, though green-ZnO NPs have shown lower cytotoxicity than physicochemically synthesized ZnO NPs (60). Studies mostly pay close attention to the improving methods for preparation of ZnO NPs (42,48,54). They focus on the physical characteristics and antibacterial abilities, but neglect, to some degree, the cytotoxicity tests in vivo. Markedly, researchers have developed a predictive model to evaluate the security of ZnO NPs with different features and the authors point out that ZnO NPs with larger size, spherical shape, negative charge and a higher tendency for aggregation are safer, which is of great value to further toxicity studies (137). Notably, ZnO NPs <100 µg/ml were biocompatible and the cytotoxicity was parallel with their antibacterial activity, which meant that the anti-S. aureus mechanism (direct contact to cells, ROS and Zn2+ releasing) was also the potential killing process in normal cells (24). Although a number of reports explained the antibacterial mechanism against S. aureus of metal and metal oxide NPs, the studies for ZnO NPs were still limited compared with other metal NPs such as Ag NPs (26,138). The majority of ZnO NPs anti-S. aureus properties lack a comprehensive assessment and were only analyzed by well or disc diffusion test and bacterial growth curve and some studies only reported ZOI or MIC or even neither of them (42,50,126). A uniform standard of S. aureus strain is also necessary, which would play a crucial role in comparing antibacterial effects of ZnO NPs made by different methods.

In order to restrict the immoderate proliferation and mutation of pathogens, unremitting efforts should be made to optimize antibacterial strategies. As aforementioned, the synergism of ZnO NPs and other materials showed complemental effects, enhanced antibacterial activity and improved properties in clinical applications. Due to technology developments, there are more potentials for ZnO NPs preparation and biomedical application. For instance, apart from the green synthesis aforementioned, material-saving, safe and even granular NPs can be made by more novel methods, such as microfluidic (120). Except for using green and easily obtained raw materials, synthetic methods should be able to flexibly control the size, shape and dispersity of ZnO NPs, which means that the key material and procedure of ZnO NPs synthesis must be identified by modern techniques. Notably, genomic and proteomic techniques should be devoted to the exploration of the antibacterial mechanism, synthesis optimization and cytotoxicity of ZnO NPs. The antibacterial study of effects at the cellular level in the long term is an essential component to investigate the dosage and safety of ZnO NPs. It is necessary to focus on ZnO NPs studies in vivo, especially the biokinetics, bioavailability, tissue distribution and clearance rate, which are essential for their antibacterial applications and improved using as antibiotics replacements. In addition, composite and functional ZnO NPs could enhance the antibacterial advantages to some degree and decrease their toxicity and also reduce the excessive exposure of ZnO NPs that diminish the possibility of antimicrobial resistance, this is for future researchers.

Acknowledgements

Not applicable.

Availability of data and materials

Not applicable.

Authors' contributions

HY and GD conceived the present study. YH, YW, LZ, FL, YJ, JL and SC performed the literature search, drafted the manuscript and drew the figures. YH wrote the manuscript. All authors read and approved the final manuscript. Data authentication is not applicable.

Ethics approval and consent to participate

Not applicable.

Patient consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Authors' information

Optional

Figure 1 The excellent properties, antibacterial mechanism against S. aureus and antibiotics delivery ability of ZnO NPs. ZnO NPs, zinc oxide nanoparticles; S. aureus, Staphylococcus aureus; ROS. reactive oxygen species.

Figure 2 Top-down and bottom-up synthesis methods of ZnO NPs. ZnO NPs, zinc oxide nanoparticles.

Figure 3 Raw materials classifications and functions of green synthesis for ZnO NPs. ZnO NPs, zinc oxide nanoparticles.

Figure 4 Substances that combined with ZnO NPs were used to make ZnO nanocomposites/nanohybrids. ZnO NPs, zinc oxide nanoparticles.

Table I The characteristics and anti-S. aureus activity of top-down and bottom-up synthesized ZnO NPs.

First author/s, year	Method type	Method	Size	Shape	Bacterial strain	MIC	ZOI	(Refs.)	
Massoudi et al, 2022	Top-down synthesis	Ball milling	148±68 nm	Hexagonal	S. aureus	 	13.5±0.5 mm	(41)	
Yusof et al, 2019	 	Microwave heating	50-130 nm	~Spherical	S. aureus	 	16 mm	(42)	
Bai et al, 2015b	 	Solvothermal synthesis	4 nm, 10 nm	Wurtzite structure	S. aureus (ATCC 6538)	6.25 and 25 µg/ml	 	(46)	
Manzoor et al, 2016	 	Mechano-chemical milling	<20 nm	Spherical	MRSA	0.625 mg/ml	 	(50)	
El-Gendy et al, 2022	 	Laser-ablation	9.8 nm	Spherical	S. aureus (ATCC 43300)	 	 	(126)	
Navarro-López et al, 2021	Bottom-up synthesis	Solution-polymerization method	<20 nm	Hexagonal wurtzite structure	S. aureus (ATCC 33594)	1 mg/ml	 	(47)	
Manyasree et al, 2018	 	Co-precipitation	35 nm	Spherical	S. aureus (MCC-2408)	4 mg/ml	24±0.35 mm	(48)	
Sajjad et al, 2021	 	Co-precipitation	17.11-22.56 nm	Spherical to hexagonal disks and rodlike	MRSA	 	23 mm	(139)	
Al-Mosawi et al, 2023	 	Wet chemical precipitation method	18.47-25.19 nm	Spherical	MRSA	25-50 µg/ml	17.62±2.65 mm	(140)	
Kim et al, 2020	 	Solvothermal synthesis	50 nm	Spherical	S. aureus	 	4 mm	(141)	
Hozyen et al, 2019	 	Sonochemical method	41 nm	Hexagonal	S. aureus	20 mg/ml	 	(142)	
Mahamuni et al, 2018	 	Polyol synthesis	15-100 nm	Oval to rod	S. aureus (NCIM 2654)	10-20 µg/ml	14 mm	(49)	
Khan et al, 2014	 	Sol-gel method	23.7-88.8 nm	Flower-shaped	S. aureus	0.5 mg/ml	23 mm	(143)	
Dadi et al, 2019b	 	Sol-gel method	3 nm	Spherical	S. aureus (ATCC 6538)	 	32 mm	(32)	
Gharpure et al, 2021	 	Co-precipitation	60-250 nm	Rod, pear and almond-shaped	S. aureus (PTCC1112) and S. aureus (ATCC6538p)	2.5 µg/ml	 	(144)	
Wahab et al, 2010	 	Non-hydrolytic solution process	20-30 nm	Spherical	S. aureus	15 µg/ml	 	(145)	
ZnO NPs, zinc oxide nanoparticles; S. aureus, Staphylococcus aureus; MRSA, methicillin-resistant Staphylococcus aureus; MIC, minimum inhibitory concentration; ZOI, zone of inhibition.

Table II The antibacterial properties against S. aureus of green-synthesized ZnO NPs.

First author/s, year	Material type	Material	ZnO NPs size	ZnO NPs shape	Bacterial strain	MIC	ZOI	(Refs.)	
Mohammed et al, 2023	Plant	Cymbopogon citratus	20-24 nm	Hexagonal rod-like	S. aureus (MTCC 9760)	88.13±0.35 µg/ml	19.60±0.66 mm	(56)	
Mushtaq et al, 2023	 	Viscum album	13.5 nm	Quasi- spherical	S. aureus (ATCC 29213)	 	40±0.3 mm	(57)	
Al-Askar et al, 2023	 	Pluchea indica	21.9 nm	Spherical	S. aureus	250 µg/ml	17.0±1.0 mm	(146)	
Hasan et al, 2022	 	Withania coagulans	25 nm	Flower-shaped	S. aureus	1.25 µg/ml	21 mm	(58)	
Ting et al, 2022	 	Andrographis paniculata	<98.61 nm	Flower-shape	S. aureus (ATCC 29737)	 	25 mm	(53)	
Irfan et al, 2022	 	Acacia modesta	70±03 nm	Rod	MRSA	 	16±0.02 mm	(59)	
Malhotra et al, 2023	 	Eupatorium odoratum	50 nm	Spherical and hexagonal	S. aureus (MTCC87)	250 µg/ml	 	(61)	
Alallam et al, 2023	 	Curcumin	27.61±5.18 nm	Grain-shaped and spherical	S. aureus	500 µg/ml	10.60±0.10 mm	(60)	
Kahandal et al, 2023	 	Locust Bean Gum	20-40 nm	Spherical	S. aureus (ATCC 6538)	125 µg/ml	 	(36)	
Sachin et al, 2023	 	Lychee	<10 nm	Spherical	S. aureus	500 µg/ml	15.0 mm	(55)	
Doğaroğlu et al, 2023	 	Mentha spicata	24.5 nm	Triangular	S. aureus (ATCC 25923)	 	17.83 mm	(54)	
Doğaroğlu et al, 2023	 	Ocimum basilicum	26.7 nm	Triangular	S. aureus (ATCC 25923)	 	16.14 mm	 	
Manojkumar et al, 2023	 	Brassica oleracea	52 nm	Flower-like	S. aureus	 	13 mm	(147)	
Irfan et al, 2021	 	Psidium guajava Linn	41.34 nm	Hexagonal	S. aureus	 	12±0.23 mm	(148)	
Jamil et al, 2020	Algae	Microalgae strain ZAA1 (MF140241)	1-100 nm	Spherical	S. aureus	 	14.5 mm	(63)	
 	 	ZAA2 (MF114592)	 	 	 	 	20 mm	 	
 	 	ZAA3 (MF114594)	 	 	 	 	14 mm	 	
Lopez-Miranda et al, 2023	 	Sargassum	20-200 nm	Irregular	S. aureus (ATCC 6538)	800 µg/ml	 	(66)	
Morowvat et al, 2023	 	Chlorella vulgaris	33.4 nm	Rod	MRSA	400 µg/ml	 	(64)	
Ebadi et al, 2019	 	cyanobacterium Nostoc sp. EA03	50-80 nm	Star-shaped	S. aureus (ATCC 25923)	64 µg/ml	 	(68)	
Ebadi et al, 2022	 	cyanobacterial strain Desertifilum sp. EAZ03	88 nm	Rod	S. aureus (ATCC 59223)	32 µg/ml	 	(67)	
Alsaggaf et al, 2021	 	Ulva fasciata Delile	77.81 nm	Flower and sphere shapes	S. aureus (ATCC 25923)	22.5 µg/ml	19.7±1.1 mm	(65)	
Mohd Yusof et al, 2020	Bacteria	Lactobacillus plantarum TA4	291.1 nm	Flower-like (ZnO NPs-CFS)	S. aureus	1250 µg/ml	16.5 mm	(71)	
 	 	 	191.8 nm	Irregular (ZnO NPs-CB)	 	312.5 µg/ml	16 mm	 	
Shaaban and El Mahdy et al, 2018	 	Streptomyces isolate S12	20-50 nm	Spherical	S. aureus (ATCC 29213)	200 µg/ml	 	(73)	
 	 	 	 	 	MRSA clinical isolates	3.25-50 µg/ml	 	 	
Rehman et al, 2019	 	Bacillus haynesii (GeneBank: MG822851)	50±5 nm	Spherical and a few rod-shaped	S. aureus (ATCC 29213)	4 mg/ml	 	(72)	
Taran et al, 2018	 	Halomonas elongata IBRC-M 10214	18.11±8.93 nm	Spherical	S. aureus (ATCC 43300)	13.6 µg/ml	 	(74)	
Kang, 2022	 	Leuconostoc sp. Strain C2	173.77± 14.53 nm	Rod	S. aureus	512 µg/ml	 	(76)	
Abdo et al, 2021	 	Pseudomonas aeruginosa	14.95±3.5 nm	Spherical	S. aureus (ATCC 6538)	200 µg/ml	12.33±0.9 mm	(149)	
Sharma et al, 2021	Fungi	Phanerochaete chrysosporium	50 nm	Hexagonal	S. aureus (MTCC-96)	0.1 µg/ml	23 mm	(77)	
Mohamed et al, 2021	 	Penicillium chrysogenum	9-35 nm	Hexagonal	S. aureus (ATCC 23235)	2 mg/ml	16.33±0.88 mm	(78)	
Sumanth, 2020	 	Xylaria acuta	34-55 nm	Hexagonal	S. aureus (NCIM No. 2079)	15.6 µg/ml	 	(79)	
Abdelkader et al, 2022	 	Aspergillus niger	31.75±4.38 nm	Spherical morphology with some hexagonal architecture	S. aureus (ATCC 29231)	8-128 µg/ml	 	(80)	
Motazedi et al, 2020	 	Saccharomyces cerevisiae	<30 nm	Spherical	S. aureus (ATCC 25923)	 	25 mm	(81)	
ZnO NPs, zinc oxide nanoparticles; S. aureus, Staphylococcus aureus; MRSA, Methicillin-resistant Staphylococcus aureus; CFS, the cell-supernatant; CB, the cell-biomass; MIC, minimum inhibitory concentration; ZOI, zone of inhibition.
==== Refs
References

1 Tong SY Davis JS Eichenberger E Holland TL Fowler VJ Staphylococcus aureus infections: Epidemiology, pathophysiology, clinical manifestations, and management Clin Microbiol Rev 28 603 661 2015 10.1128/CMR.00134-14 26016486
2 Wang Y Zhang P Wu J Chen S Jin Y Long J Duan G Yang H Transmission of livestock-associated methicillin-resistant Staphylococcus aureus between animals, environment, and humans in the farm Environ Sci Pollut Res Int 30 86521 86539 2023 10.1007/s11356-023-28532-7 37418185
3 Willyard C Drug-resistant bacteria ranked Nature (London) 543 15 2017
4 Hou H Li Y Jin Y Chen S Long J Duan G Yang H The crafty opponent: The defense systems of Staphylococcus aureus and response measures Folia Microbiol (Praha) 67 233 243 2022 10.1007/s12223-022-00954-9 35149955
5 Lakhundi S Zhang K Methicillin-zesistant Staphylococcus aureus: Molecular characterization, evolution, and epidemiology Clin Microbiol Rev 31 e00020 18 2018 10.1128/CMR.00020-18 30209034
6 Gong C Guan W Liu X Zheng Y Li Z Zhang Y Zhu S Jiang H Cui Z Wu S Biomimetic bacteriophage-like particles formed from probiotic extracts and NO donors for eradicating multidrug-resistant Staphylococcus aureus Adv Mater 34 e2206134 2022 10.1002/adma.202206134 36111564
7 Plumet L Ahmad-Mansour N Dunyach-Remy C Kissa K Sotto A Lavigne JP Costechareyre D Molle V Bacteriophage therapy for Staphylococcus aureus infections: A Review of animal models, treatments, and clinical trials Front Cell Infect Microbiol 12 907314 2022 10.3389/fcimb.2022.907314 35782148
8 Chand U Priyambada P Kushawaha PK Staphylococcus aureus vaccine strategy: Promise and challenges Microbiol Res 271 127362 2023 10.1016/j.micres.2023.127362 36958134
9 Miller LS Fowler VG Shukla SK Rose WE Proctor RA Development of a vaccine against Staphylococcus aureus invasive infections: Evidence based on human immunity, genetics and bacterial evasion mechanisms FEMS Microbiol Rev 44 123 153 2020 10.1093/femsre/fuz030 31841134
10 Super M Doherty EJ Cartwright MJ Seiler BT Langellotto F Dimitrakakis N White DA Stafford AG Karkada M Graveline AR Biomaterial vaccines capturing pathogen-associated molecular patterns protect against bacterial infections and septic shock Nat Biomed Eng 6 8 18 2022 10.1038/s41551-021-00756-3 34239117
11 de Vor L van Dijk B van Kessel K Kavanaugh JS de Haas C Aerts PC Viveen MC Boel EC Fluit AC Kwiecinski JM Human monoclonal antibodies against Staphylococcus aureus surface antigens recognize in vitro and in vivo biofilm Elife 11 e67301 2022 10.7554/eLife.67301 34989676
12 Raafat D Otto M Reppschlager K Iqbal J Holtfreter S Fighting Staphylococcus aureus biofilms with monoclonal antibodies Trends Microbiol 27 303 322 2019 10.1016/j.tim.2018.12.009 30665698
13 Haddad Kashani H Schmelcher M Sabzalipoor H Seyed Hosseini E Moniri R Recombinant endolysins as potential therapeutics against antibiotic-resistant Staphylococcus aureus: Current status of research and novel delivery strategies Clin Microbiol Rev 31 e00071 17 2017 10.1128/CMR.00071-17 29187396
14 Defraine V Fauvart M Michiels J Fighting bacterial persistence: Current and emerging anti-persister strategies and therapeutics Drug Resist Updat 38 12 26 2018 10.1016/j.drup.2018.03.002 29857815
15 Ganesan N Mishra B Felix L Mylonakis E Antimicrobial peptides and small molecules targeting the cell membrane of Staphylococcus aureus Microbiol Mol Biol Rev 87 e0003722 2023 10.1128/mmbr.00037-22 37129495
16 Hou X Li J Tang H Li Q Shen G Li S Chen A Peng Z Zhang Y Li C Zhang Z Antibacterial peptide NP-6 affects Staphylococcus aureus by multiple modes of action Int J Mol Sci 23 7812 2022 10.3390/ijms23147812 35887160
17 Li J Liu D Tian X Koseki S Chen S Ye X Ding T Novel antibacterial modalities against methicillin resistant Staphylococcus aureus derived from plants Crit Rev Food Sci Nutr 59 (Suppl 1) S153 S161 2019 10.1080/10408398.2018.1541865 30501508
18 Pirzadeh M Caporaso N Rauf A Shariati MA Yessimbekov Z Khan MU Imran M Mubarak MS Pomegranate as a source of bioactive constituents: A review on their characterization, properties and applications Crit Rev Food Sci Nutr 61 982 999 2021 10.1080/10408398.2020.1749825 32314615
19 Vestergaard M Ingmer H Antibacterial and antifungal properties of resveratrol Int J Antimicrob Agents 53 716 723 2019 10.1016/j.ijantimicag.2019.02.015 30825504
20 Rai M Ingle AP Pandit R Paralikar P Gupta I Chaud MV Dos Santos CA Broadening the spectrum of small-molecule antibacterials by metallic nanoparticles to overcome microbial resistance Int J Pharm 532 139 148 2017 10.1016/j.ijpharm.2017.08.127 28870767
21 Zahran M Marei AH Innovative natural polymer metal nanocomposites and their antimicrobial activity Int J Biol Macromol 136 586 596 2019 10.1016/j.ijbiomac.2019.06.114 31220496
22 Makabenta JMV Nabawy A Li CH Schmidt-Malan S Patel R Rotello VM Nanomaterial-based therapeutics for antibiotic-resistant bacterial infections Nat Rev Microbiol 19 23 36 2021 10.1038/s41579-020-0420-1 32814862
23 Yuan Z Lin C Dai L He Y Hu J Xu K Tao B Liu P Cai K Near-infrared light-activatable dual-action nanoparticle combats the established biofilms of methicillin-resistant Staphylococcus aureus and its accompanying inflammation Small 17 e2007522 2021 10.1002/smll.202007522 33690998
24 Babayevska N Przysiecka Ł Iatsunskyi I Nowaczyk G Jarek M Janiszewska E Jurga S ZnO size and shape effect on antibacterial activity and cytotoxicity profile Sci Rep 12 8148 2022 10.1038/s41598-022-12134-3 35581357
25 Wang Y Yang Y Shi Y Song H Yu C Antibiotic-free antibacterial strategies enabled by nanomaterials: Progress and perspectives Adv Mater 32 e1904106 2020 10.1002/adma.201904106 31799752
26 Maťátková O Michailidu J Miškovská A Kolouchová I Masák J Čejková A Antimicrobial properties and applications of metal nanoparticles biosynthesized by green methods Biotechnol Adv 58 107905 2022 10.1016/j.biotechadv.2022.107905 35031394
27 Wang L Hu C Shao L The antimicrobial activity of nanoparticles: Present situation and prospects for the future Int J Nanomedicine 12 1227 1249 2017 10.2147/IJN.S121956 28243086
28 Alzahrani KE Niazy AA Alswieleh AM Wahab R El-Toni AM Alghamdi HS Antibacterial activity of trimetal (CuZnFe) oxide nanoparticles Int J Nanomedicine 13 77 87 2017 10.2147/IJN.S154218 29317817
29 Roszczenko P Szewczyk OK Czarnomysy R Bielawski K Bielawska A Biosynthesized gold, silver, palladium, platinum, copper, and other transition metal nanoparticles Pharmaceutics 14 2286 2022 10.3390/pharmaceutics14112286 36365105
30 Slavin YN Asnis J Häfeli UO Bach H Metal nanoparticles: Understanding the mechanisms behind antibacterial activity J Nanobiotechnology 15 65 2017 10.1186/s12951-017-0308-z 28974225
31 Huang X Zheng X Xu Z Yi C ZnO-based nanocarriers for drug delivery application: From passive to smart strategies Int J Pharm 534 190 194 2017 10.1016/j.ijpharm.2017.10.008 29038062
32 Dadi R Azouani R Traore M Mielcarek C Kanaev A Antibacterial activity of ZnO and CuO nanoparticles against gram positive and gram negative strains Mater Sci Eng C Mater Biol Appl 104 109968 2019 10.1016/j.msec.2019.109968 31500003
33 Kalpana VN Devi Rajeswari V A Review on green synthesis, biomedical applications, and toxicity studies of ZnO NPs Bioinorg Chem Appl 2018 3569758 2018 10.1155/2018/3569758 30154832
34 Lallo da Silva B Caetano BL Chiari-Andréo BG Pietro RCLR Chiavacci LA Increased antibacterial activity of ZnO nanoparticles: Influence of size and surface modification Colloids Surf B Biointerfaces 177 440 447 2019 10.1016/j.colsurfb.2019.02.013 30798065
35 Bianchini Fulindi R Domingues Rodrigues J Lemos Barbosa TW Goncalves Garcia AD de Almeida La Porta F Pratavieira S Chiavacci LA Pessoa Araújo Junior J da Costa PI Martinez LR Zinc-based nanoparticles reduce bacterial biofilm formation Microbiol Spectr 11 e0483122 2023 10.1128/spectrum.04831-22 (Epub ahead of print) 36853055
36 Kahandal A Chaudhary S Methe S Nagwade P Sivaram A Tagad CK Galactomannan polysaccharide as a biotemplate for the synthesis of zinc oxide nanoparticles with photocatalytic, antimicrobial and anticancer applications Int J Biol Macromol 253 126787 2023 10.1016/j.ijbiomac.2023.126787 37690639
37 Abdelraheem WM Khairy RMM Zaki AI Zaki SH Effect of ZnO nanoparticles on methicillin, vancomycin, linezolid resistance and biofilm formation in Staphylococcus aureus isolates Ann Clin Microbiol Antimicrob 20 54 2021 10.1186/s12941-021-00459-2 34419054
38 Irfan M Munir H Ismail H Moringa oleifera gum based silver and zinc oxide nanoparticles: Green synthesis, characterization and their antibacterial potential against MRSA Biomater Res 25 17 2021 10.1186/s40824-021-00219-5 33964968
39 El-Masry RM Talat D Hassoubah SA Zabermawi NM Eleiwa NZ Sherif RM Abourehab MSA Abdel-Sattar RM Gamal M Ibrahim MS Elbestawy A Evaluation of the antimicrobial activity of ZnO nanoparticles against enterotoxigenic Staphylococcus aureus Life (Basel) 12 1662 2022 10.3390/life12101662 36295097
40 Bommakanti V Banerjee M Shah D Manisha K Sri K Banerjee S An overview of synthesis, characterization, applications and associated adverse effects of bioactive nanoparticles Environ Res 214 113919 2022 10.1016/j.envres.2022.113919 35863448
41 Massoudi I Hamdi R Ababutain I Alhussain E Kharma A HSBM-produced zinc oxide nanoparticles: Physical properties and evaluation of their antimicrobial activity against human pathogens Scientifica (Cairo) 2022 9989282 2022 10.1155/2022/9989282 36591557
42 Yusof NAA Zain NM Pauzi N Synthesis of ZnO nanoparticles with chitosan as stabilizing agent and their antibacterial properties against Gram-positive and Gram-negative bacteria Int J Biol Macromol 124 1132 1136 2019 10.1016/j.ijbiomac.2018.11.228 30496864
43 Asif N Amir M Fatma T Recent advances in the synthesis, characterization and biomedical applications of zinc oxide nanoparticles Bioprocess Biosyst Eng 46 1377 1398 2023 10.1007/s00449-023-02886-1 37294320
44 Mendes AR Granadeiro CM Leite A Pereira E Teixeira P Poças F optimizing antimicrobial efficacy: Investigating the impact of zinc oxide nanoparticle shape and size Nanomaterials (Basel) 14 638 2024 10.3390/nano14070638 38607172
45 Stankic S Suman S Haque F Vidic J Pure and multi metal oxide nanoparticles: Synthesis, antibacterial and cytotoxic properties J Nanobiotechnology 14 73 2016 10.1186/s12951-016-0225-6 27776555
46 Bai X Li L Liu H Tan L Liu T Meng X Solvothermal synthesis of ZnO nanoparticles and anti-infection application in vivo ACS Appl Mater Interfaces 7 1308 1317 2015 10.1021/am507532p 25537255
47 Navarro-López DE Garcia-Varela R Ceballos-Sanchez O Sanchez-Martinez A Sanchez-Ante G Corona-Romero K Buentello-Montoya DA Elías-Zuñiga A López-Mena ER Effective antimicrobial activity of ZnO and Yb-doped ZnO nanoparticles against Staphylococcus aureus and Escherichia coli Mater Sci Eng C Mater Biol Appl 123 112004 2021 10.1016/j.msec.2021.112004 33812624
48 Manyasree D Kiranmayi P Kolli VR Characterization and antibacterial activity of zno nanoparticles synthesized by co precipitation method Int J Appl Pharm 10 224 2018
49 Mahamuni PP Patil PM Dhanavade MJ Badiger MV Shadija PG Lokhande AC Bohara RA Synthesis and characterization of zinc oxide nanoparticles by using polyol chemistry for their antimicrobial and antibiofilm activity Biochem Biophys Rep 17 71 80 2018 10.1016/j.bbrep.2018.11.007 30582010
50 Manzoor U Siddique S Ahmed R Noreen Z Bokhari H Ahmad I Antibacterial, structural and optical characterization of mechano-chemically prepared ZnO nanoparticles PLoS One 11 e0154704 2016 10.1371/journal.pone.0154704 27183165
51 Paiva-Santos AC Herdade AM Guerra C Peixoto D Pereira-Silva M Zeinali M Mascarenhas-Melo F Paranhos A Veiga F Plant-mediated green synthesis of metal-based nanoparticles for dermopharmaceutical and cosmetic applications Int J Pharm 597 120311 2021 10.1016/j.ijpharm.2021.120311 33539998
52 Salem SS Fouda A Green synthesis of metallic nanoparticles and their prospective biotechnological applications: An overview Biol Trace Elem Res 199 344 370 2021 10.1007/s12011-020-02138-3 32377944
53 Ting BYS Fuloria NK Subrimanyan V Bajaj S Chinni SV Reddy LV Sathasivam KV Karupiah S Malviya R Meenakshi DU Biosynthesis and response of zinc oxide nanoparticles against periimplantitis triggering pathogens Materials (Basel) 15 3170 2022 10.3390/ma15093170 35591502
54 Doğaroğlu ZG Uysal Y çaylalı Z Karakulak DS Green nanotechnology advances: Green manufacturing of zinc nanoparticles, characterization, and foliar application on wheat and antibacterial characteristics using Mentha spicata (mint) and Ocimum basilicum (basil) leaf extracts Environ Sci Pollut Res Int 30 60820 60837 2023 10.1007/s11356-023-26827-3 37039921
55 Sachin Jaishree Singh N Singh R Shah K Pramanik BK Green synthesis of zinc oxide nanoparticles using lychee peel and its application in anti-bacterial properties and CR dye removal from wastewater Chemosphere 327 138497 2023 10.1016/j.chemosphere.2023.138497 37001759
56 Mohammed YHI Alghamdi S Jabbar B Marghani D Beigh S Abouzied AS Khalifa NE Khojali WMA Huwaimel B Alkhalifah DHM Hozzein WN Green synthesis of zinc oxide nanoparticles using Cymbopogon citratus extract and its antibacterial activity ACS Omega 8 32027 32042 2023 10.1021/acsomega.3c03908 37692252
57 Mushtaq W Ishtiaq M Maqbool M Mazhar MW Casini R Abd-Elgawad AM Elansary HO Green synthesis of zinc oxide nanoparticles using Viscum album extracts: Unveiling bioactive compounds, antibacterial potential, and antioxidant activities Plants (Basel) 12 2130 2023 10.3390/plants12112130 37299109
58 Hasan M Zafar A Imran M Iqbal KJ Tariq T Iqbal J Shaheen A Hussain R Anjum SI Shu X Crest to trough cellular drifting of green-synthesized zinc oxide and silver nanoparticles ACS Omega 7 34770 34778 2022 10.1021/acsomega.2c02178 36211074
59 Irfan M Munir H Ismail H Characterization and fabrication of zinc oxide nanoparticles by gum Acacia modesta through green chemistry and impregnation on surgical sutures to boost up the wound healing process Int J Biol Macromol 204 466 475 2022 10.1016/j.ijbiomac.2022.02.043 35157899
60 Alallam B Doolaanea AA Alfatama M Lim V Phytofabrication and characterisation of zinc oxide nanoparticles using pure curcumin Pharmaceuticals (Basel) 16 269 2023 10.3390/ph16020269 37259414
61 Malhotra A Chauhan SR Rahaman M Tripathi R Khanuja M Chauhan A Phyto-assisted synthesis of zinc oxide nanoparticles for developing antibiofilm surface coatings on central venous catheters Front Chem 11 1138333 2023 10.3389/fchem.2023.1138333 37035110
62 Khanna P Kaur A Goyal D Algae-based metallic nanoparticles: Synthesis, characterization and applications J Microbiol Methods 163 105656 2019 10.1016/j.mimet.2019.105656 31220512
63 Jamil Z Naqvi STQ Rasul S Hussain SB Fatima N Qadir MI Muhammad SA Antibacterial activity and characterization of zinc oxide nanoparticles synthesized by microalgae Pak J Pharm Sci 33 2497 2504 2020 33867322
64 Morowvat MH Kazemi K Jaberi MA Amini A Gholami A Biosynthesis and antimicrobial evaluation of zinc oxide nanoparticles using Chlorella vulgaris biomass against multidrug-resistant pathogens Materials (Basel) 16 842 2023 10.3390/ma16020842 36676578
65 Alsaggaf MS Diab AM Elsaied BEF Tayel AA Moussa SH Application of ZnO nanoparticles phycosynthesized with Ulva fasciata extract for preserving peeled shrimp quality Nanomaterials (Basel) 11 385 2021 10.3390/nano11020385 33546265
66 Lopez-Miranda JL Molina GA González-Reyna MA España-Sánchez BL Esparza R Silva R Estévez M Antibacterial and anti-inflammatory properties of ZnO nanoparticles synthesized by a green method using Sargassum extracts Int J Mol Sci 24 1474 2023 10.3390/ijms24021474 36674991
67 Ebadi M Zolfaghari MR Aghaei SS Zargar M Noghabi KA Desertifilum sp. EAZ03 cell extract as a novel natural source for the biosynthesis of zinc oxide nanoparticles and antibacterial, anticancer and antibiofilm characteristics of synthesized zinc oxide nanoparticles J Appl Microbiol 132 221 236 2022 10.1111/jam.15177 34101961
68 Ebadi M Zolfaghari MR Aghaei SS Zargar M Shafiei M Zahiri HS Noghabi KA A bio-inspired strategy for the synthesis of zinc oxide nanoparticles (ZnO NPs) using the cell extract of cyanobacterium Nostoc sp. EA03: From biological function to toxicity evaluation RSC Adv 9 23508 23525 2019 10.1039/c9ra03962g 35530580
69 Barani M Masoudi M Mashreghi M Makhdoumi A Eshghi H Cell-free extract assisted synthesis of ZnO nanoparticles using aquatic bacterial strains: Biological activities and toxicological evaluation Int J Pharm 606 120878 2021 10.1016/j.ijpharm.2021.120878 34265392
70 Dikshit P Kumar J Das AK Sadhu S Sharma S Singh S Gupta PK Kim BS Green synthesis of metallic nanoparticles: Applications and limitations Catalysts 11 902 2021
71 Mohd Yusof H Abdul Rahman NA Mohamad R Zaidan UH Samsudin AA Biosynthesis of zinc oxide nanoparticles by cell-biomass and supernatant of Lactobacillus plantarum TA4 and its antibacterial and biocompatibility properties Sci Rep 10 19996 2020 10.1038/s41598-020-76402-w 33204003
72 Rehman S Jermy BR Akhtar S Borgio JF Abdul AS Ravinayagam V Al Jindan R Alsalem ZH Buhameid A Gani A Isolation and characterization of a novel thermophile; Bacillus haynesii, applied for the green synthesis of ZnO nanoparticles Artif Cells Nanomed Biotechnol 47 2072 2082 2019 10.1080/21691401.2019.1620254 31126203
73 Shaaban M El-Mahdy AM Biosynthesis of Ag, Se, and ZnO nanoparticles with antimicrobial activities against resistant pathogens using waste isolate Streptomyces enissocaesilis IET Nanobiotechnol 12 741 747 2018 10.1049/iet-nbt.2017.0213 30104447
74 Taran M Rad M Alavi M Biosynthesis of TiO2 and ZnO nanoparticles by Halomonas elongata IBRC-M 10214 in different conditions of medium Bioimpacts 8 81 89 2018 10.15171/bi.2018.10 29977829
75 Taran M Amirkhani H Strategies of poly(3-hydroxybutyrate) synthesis by Haloarcula sp. IRU1 utilizing glucose as carbon source: Optimization of culture conditions by Taguchi methodology Int J Biol Macromol 47 632 634 2010 10.1016/j.ijbiomac.2010.08.008 20728468
76 Kang MG Khan F Jo DM Oh D Tabassum N Kim YM Antibiofilm and antivirulence activities of gold and zinc oxide nanoparticles synthesized from kimchi-isolated Leuconostoc sp. Strain C2 Antibiotics (Basel) 11 1524 2022 10.3390/antibiotics11111524 36358180
77 Sharma JL Dhayal V Sharma RK White-rot fungus mediated green synthesis of zinc oxide nanoparticles and their impregnation on cellulose to develop environmental friendly antimicrobial fibers 3 Biotech 11 269 2021 10.1007/s13205-021-02840-6 34017675
78 Mohamed AA Abu-Elghait M Ahmed NE Salem SS Eco-friendly mycogenic synthesis of ZnO and CuO nanoparticles for in vitro antibacterial, antibiofilm, and antifungal applications Biol Trace Elem Res 199 2788 2799 2021 10.1007/s12011-020-02369-4 32895893
79 Sumanth B Lakshmeesha TR Ansari MA Alzohairy MA Udayashankar AC Shobha B Niranjana SR Srinivas C Almatroudi A Mycogenic synthesis of extracellular zinc oxide nanoparticles from Xylaria acuta and its nanoantibiotic potential Int J Nanomedicine 15 8519 8536 2020 10.2147/IJN.S271743 33173290
80 Abdelkader DH Negm WA Elekhnawy E Eliwa D Aldosari BN Almurshedi AS Zinc oxide nanoparticles as potential delivery carrier: Green synthesis by Aspergillus niger Endophytic fungus, characterization, and in vitro/in vivo antibacterial activity Pharmaceuticals (Basel) 15 1057 2022 10.3390/ph15091057 36145278
81 Motazedi R Rahaiee S Zare M Efficient biogenesis of ZnO nanoparticles using extracellular extract of Saccharomyces cerevisiae: Evaluation of photocatalytic, cytotoxic and other biological activities Bioorg Chem 101 103998 2020 10.1016/j.bioorg.2020.103998 32554276
82 Akbar N Aslam Z Siddiqui R Shah MR Khan NA Zinc oxide nanoparticles conjugated with clinically-approved medicines as potential antibacterial molecules AMB Express 11 104 2021 10.1186/s13568-021-01261-1 34245385
83 Ghaffar N Javad S Farrukh MA Shah AA Gatasheh MK Al-Munqedhi BMA Chaudhry O Metal nanoparticles assisted revival of Streptomycin against MDRS Staphylococcus aureus PLoS One 17 e0264588 2022 10.1371/journal.pone.0264588 35324924
84 Nejabatdoust A Zamani H Salehzadeh A Functionalization of ZnO nanoparticles by glutamic acid and conjugation with thiosemicarbazide alters expression of efflux pump genes in multiple drug-resistant Staphylococcus aureus strains Microb Drug Resist 25 966 974 2019 10.1089/mdr.2018.0304 30855211
85 Habib S Rashid F Tahir H Liaqat I Latif AA Naseem S Khalid A Haider N Hani U Dawoud RA Antibacterial and cytotoxic effects of biosynthesized zinc oxide and titanium dioxide nanoparticles Microorganisms 11 1363 2023 10.3390/microorganisms11061363 37374866
86 Abdelghafar A Yousef N Askoura M Zinc oxide nanoparticles reduce biofilm formation, synergize antibiotics action and attenuate Staphylococcus aureus virulence in host; an important message to clinicians BMC Microbiol 22 244 2022 10.1186/s12866-022-02658-z 36221053
87 Hemmati F Salehi R Ghotaslou R Kafil HS Hasani A Gholizadeh P Rezaee MA The assessment of antibiofilm activity of chitosan-zinc oxide-gentamicin nanocomposite on Pseudomonas aeruginosa and Staphylococcus aureus Int J Biol Macromol 163 2248 2258 2020 10.1016/j.ijbiomac.2020.09.037 32920055
88 Saddik MS Elsayed MMA El-Mokhtar MA Sedky H Abdel-Aleem JA Abu-Dief AM Al-Hakkani MF Hussein HL Al-Shelkamy SA Meligy FY Tailoring of novel azithromycin-loaded zinc oxide nanoparticles for wound healing Pharmaceutics 14 111 2022 10.3390/pharmaceutics14010111 35057019
89 Khan SA Shahid S Mahmood T Lee CS Contact lenses coated with hybrid multifunctional ternary nanocoatings (phytomolecule-coated ZnO nanoparticles:Gallic acid:Tobramycin) for the treatment of bacterial and fungal keratitis Acta Biomater 128 262 276 2021 10.1016/j.actbio.2021.04.014 33866034
90 Rath G Hussain T Chauhan G Garg T Goyal AK Development and characterization of cefazolin loaded zinc oxide nanoparticles composite gelatin nanofiber mats for postoperative surgical wounds Mater Sci Eng C Mater Biol Appl 58 242 253 2016 10.1016/j.msec.2015.08.050 26478308
91 Oves M Rauf MA Ansari MO Aslam Parwaz Khan A A Qari H Alajmi MF Sau S Iyer AK Graphene decorated zinc oxide and curcumin to disinfect the methicillin-resistant Staphylococcus aureus Nanomaterials (Basel) 10 1004 2020 10.3390/nano10051004 32466085
92 Zhai F Luo Y Zhang Y Liao S Cheng J Meng X Zeng Y Wang X Yang J Yin J Li L Viscosity simulation of glass microfiber and an unusual air filter with high-efficiency antibacterial functionality enabled by ZnO/graphene-modified glass microfiber ACS Omega 7 14211 14221 2022 10.1021/acsomega.2c00838 35559200
93 Chai Q Wu Q Liu T Tan L Fu C Ren X Yang Y Meng X Enhanced antibacterial activity of silica nanorattles with ZnO combination nanoparticles against methicillin-resistant Staphylococcus aureus Sci Bull (Beijing) 62 1207 1215 2017 10.1016/j.scib.2017.08.016 36659515
94 Vinotha V Yazhiniprabha M Jeyavani J Vaseeharan B Synthesis and characterization of cry protein coated zinc oxide nanocomposites and its assessment against bacterial biofilm and mosquito vectors Int J Biol Macromol 208 935 947 2022 10.1016/j.ijbiomac.2022.03.165 35364199
95 Azizi-Lalabadi M Ehsani A Divband B Alizadeh-Sani M Antimicrobial activity of titanium dioxide and zinc oxide nanoparticles supported in 4A zeolite and evaluation the morphological characteristic Sci Rep 9 17439 2019 10.1038/s41598-019-54025-0 31767932
96 Banerjee S Vishakha K Das S Dutta M Mukherjee D Mondal J Mondal S Ganguli A Antibacterial, anti-biofilm activity and mechanism of action of pancreatin doped zinc oxide nanoparticles against methicillin resistant Staphylococcus aureus Colloids Surf B Biointerfaces 190 110921 2020 10.1016/j.colsurfb.2020.110921 32172163
97 Canales DA Piñones N Saavedra M Loyo C Palza H Peponi L Leonés A Baier RV Boccaccini AR Grünelwald A Zapata PA Fabrication and assessment of bifunctional electrospun poly(l-lactic acid) scaffolds with bioglass and zinc oxide nanoparticles for bone tissue engineering Int J Biol Macromol 228 78 88 2023 10.1016/j.ijbiomac.2022.12.195 36565827
98 Pitpisutkul V Prachayawarakorn J Hydroxypropyl methylcellulose/carboxymethyl starch/zinc oxide porous nanocomposite films for wound dressing application Carbohydr Polym 298 120082 2022 10.1016/j.carbpol.2022.120082 36241320
99 Majeed A Javed F Akhtar S Saleem U Anwar F Ahmad B Nadhman A Shahnaz G Hussain I Hussain SZ Sohail MF Green synthesized selenium doped zinc oxide nano-antibiotic: Synthesis, characterization and evaluation of antimicrobial, nanotoxicity and teratogenicity potential J Mater Chem B 8 8444 8458 2020 10.1039/d0tb01553a 32812631
100 Zabihi E Arab-Bafrani Z Hoseini SM Mousavi E Babaei A Khalili M Hashemi MM Javid N Fabrication of nano-decorated ZnO-fibrillar chitosan exhibiting a superior performance as a promising replacement for conventional ZnO Carbohydr Polym 274 118639 2021 10.1016/j.carbpol.2021.118639 34702461
101 Karthikeyan C Tharmalingam N Varaprasad K Mylonakis E Yallapu MM Biocidal and biocompatible hybrid nanomaterials from biomolecule chitosan, alginate and ZnO Carbohydr Polym 274 118646 2021 10.1016/j.carbpol.2021.118646 34702465
102 Kang J Hu C Dichiara A Guan L Yun H Gu J Facile preparation of cellulose nanocrystals/ZnO hybrids using acidified ZnCl2 as cellulose hydrolytic media and ZnO precursor Int J Biol Macromol 227 863 871 2023 10.1016/j.ijbiomac.2022.12.107 36535352
103 AbouAitah K Piotrowska U Wojnarowicz J Swiderska-Sroda A El-Desoky AHH Lojkowski W Enhanced activity and sustained release of protocatechuic acid, a natural antibacterial agent, from hybrid nanoformulations with zinc oxide nanoparticles Int J Mol Sci 22 5287 2021 10.3390/ijms22105287 34069756
104 Naserian F Mesgar AS Development of antibacterial and superabsorbent wound composite sponges containing carboxymethyl cellulose/gelatin/Cu-doped ZnO nanoparticles Colloids Surf B Biointerfaces 218 112729 2022 10.1016/j.colsurfb.2022.112729 35907356
105 Nageswara Rao B Tirupathi Rao P Vasudha K Esub Basha S Prasanna DSL Bhushana Rao T Samatha K Ramachandra RK Physiochemical characterization of sodium doped zinc oxide nano powder for antimicrobial applications Spectrochim Acta A Mol Biomol Spectrosc 291 122297 2023 10.1016/j.saa.2022.122297 36634496
106 Fu F Gu J Zhang R Xu X Yu X Liu L Liu X Zhou J Yao J Three-dimensional cellulose based silver-functionalized ZnO nanocomposite with controlled geometry: Synthesis, characterization and properties J Colloid Interface Sci 530 433 443 2018 10.1016/j.jcis.2018.07.009 29990779
107 Hu M Li C Li X Zhou M Sun J Sheng F Shi S Lu L Zinc oxide/silver bimetallic nanoencapsulated in PVP/PCL nanofibres for improved antibacterial activity Artif Cells Nanomed Biotechnol 46 1248 1257 2018 10.1080/21691401.2017.1366339 28826242
108 Mohammadi-Aloucheh R Habibi-Yangjeh A Bayrami A Latifi-Navid S Asadi A Enhanced anti-bacterial activities of ZnO nanoparticles and ZnO/CuO nanocomposites synthesized using Vaccinium arctostaphylos L. fruit extract Artif Cells Nanomed Biotechnol 46 (Suppl 1) S1200 S1209 2018 10.1080/21691401.2018.1448988 29527924
109 Bahari A Roeinfard M Ramzannezhad A Khodabakhshi M Mohseni M Nanostructured Features and Antimicrobial Properties of Fe3O4/ZnO Nanocomposites Natl Acad Sci Lett 42 9 12 2019
110 AlSalhi MS Devanesan S Asemi N Ahamed A Concurrent fabrication of ZnO-ZnFe2O4 hybrid nanocomposite for enhancing photocatalytic degradation of organic pollutants and its bacterial inactivation Chemosphere 318 137928 2023 10.1016/j.chemosphere.2023.137928 36706811
111 Lee M Han SI Kim C Velumani S Han A Kassiba AH Castaneda H ZrO2/ZnO/TiO2 nanocomposite coatings on stainless steel for improved corrosion resistance, biocompatibility, and antimicrobial activity ACS Appl Mater Interfaces 14 13801 13811 2022 10.1021/acsami.1c19498 35261228
112 Pulit-Prociak J Staroń A Staroń P Chmielowiec-Korzeniowska A Drabik A Tymczyna L Banach M Preparation and of PVA-based compositions with embedded silver, copper and zinc oxide nanoparticles and assessment of their antibacterial properties J Nanobiotechnology 18 148 2020 10.1186/s12951-020-00702-6 33087105
113 Akhil K Jayakumar J Gayathri G Khan SS Effect of various capping agents on photocatalytic, antibacterial and antibiofilm activities of ZnO nanoparticles J Photochem Photobiol B 160 32 42 2016 10.1016/j.jphotobiol.2016.03.015 27088507
114 Choi KH Nam KC Lee SY Cho G Jung JS Kim HJ Park BJ Antioxidant potential and antibacterial efficiency of caffeic acid-functionalized ZnO nanoparticles Nanomaterials (Basel) 7 148 2017 10.3390/nano7060148 28621707
115 Du M Zhao W Ma R Xu H Zhu Y Shan C Liu K Zhuang J Jiao Z Visible-light-driven photocatalytic inactivation of S. aureus in aqueous environment by hydrophilic zinc oxide (ZnO) nanoparticles based on the interfacial electron transfer in S. aureus/ZnO composites J Hazard Mater 418 126013 2021 10.1016/j.jhazmat.2021.126013 34102362
116 Charoensri K Rodwihok C Wongratanaphisan D Ko JA Chung JS Park HJ Investigation of functionalized surface charges of thermoplastic starch/zinc oxide nanocomposite films using polyaniline: The potential of improved antibacterial properties Polymers (Basel) 13 425 2021 10.3390/polym13030425 33525720
117 Lee J Choi KH Min J Kim HJ Jee JP Park BJ Functionalized ZnO nanoparticles with gallic acid for antioxidant and antibacterial activity against methicillin-resistant S. aureus Nanomaterials (Basel) 7 365 2017 10.3390/nano7110365 29099064
118 Chen J Jing Q Xu Y Lin Y Mai Y Chen L Wang G Chen Z Deng L Chen J Functionalized zinc oxide microparticles for improving the antimicrobial effects of skin-care products and wound-care medicines Biomater Adv 135 212728 2022 10.1016/j.bioadv.2022.212728 35929206
119 Yuan K Liu X Shi J Liu W Liu K Lu H Wu D Chen Z Lu C Antibacterial properties and mechanism of lysozyme-modified ZnO nanoparticles Front Chem 9 762255 2021 10.3389/fchem.2021.762255 34900934
120 Popa ML Preda MD Neacșu IA Grumezescu AM Ginghină O Traditional vs microfluidic synthesis of ZnO nanoparticles Int J Mol Sci 24 1875 2023 10.3390/ijms24031875 36768199
121 Ahmed S Annu Chaudhry SA Ikram S A review on biogenic synthesis of ZnO nanoparticles using plant extracts and microbes: A prospect towards green chemistry J Photochem Photobiol B 166 272 284 2017 10.1016/j.jphotobiol.2016.12.011 28013182
122 Kapp K Orav A Roasto M Raal A Püssa T Vuorela H Tammela P Vuorela P Composition and antibacterial effect of mint flavorings in candies and food supplements Planta Med 86 1089 1096 2020 10.1055/a-1158-1699 32365392
123 Deng Z Bheemanaboina RRY Luo Y Zhou CH Aloe emodin-conjugated sulfonyl hydrazones as novel type of antibacterial modulators against S. aureus 25923 through multifaceted synergistic effects Bioorg Chem 127 106035 2022 10.1016/j.bioorg.2022.106035 35870413
124 Hussain Y Alam W Ullah H Dacrema M Daglia M Khan H Arciola CR Antimicrobial potential of curcumin: Therapeutic potential and challenges to clinical applications Antibiotics (Basel) 11 322 2022 10.3390/antibiotics11030322 35326785
125 Singh P Garg A Pandit S Mokkapati VRSS Mijakovic I Antimicrobial effects of biogenic nanoparticles Nanomaterials (Basel) 8 1009 2018 10.3390/nano8121009 30563095
126 El-Gendy AO Nawaf KT Ahmed E Samir A Hamblin MR Hassan M Mohamed T Preparation of zinc oxide nanoparticles using laser-ablation technique: Retinal epithelial cell (ARPE-19) biocompatibility and antimicrobial activity when activated with femtosecond laser J Photochem Photobiol B 234 112540 2022 10.1016/j.jphotobiol.2022.112540 35973287
127 Sindelo A Nene L Nyokong T Photodynamic antimicrobial chemotherapy with asymmetrical cationic or neutral metallophthalocyanines conjugated to amino-functionalized zinc oxide nanoparticles (spherical or pyramidal) against planktonic and biofilm microbial cultures Photodiagnosis Photodyn Ther 40 103160 2022 10.1016/j.pdpdt.2022.103160 36244683
128 Ruan Q Yuan L Gao S Ji X Shao W Ma J Jiang D Development of ZnO/selenium nanoparticles embedded chitosan-based anti-bacterial wound dressing for potential healing ability and nursing care after paediatric fracture surgery Int Wound J 20 1819 1831 2023 10.1111/iwj.13947 36992557
129 Ismail A Raya NR Orabi A Ali AM Abo-Zeid Y Investigating the antibacterial activity and safety of zinc oxide nanoparticles versus a commercial alcohol-based hand-sanitizer: Can zinc oxide nanoparticles be useful for hand sanitation? Antibiotics (Basel) 11 1606 2022 10.3390/antibiotics11111606 36421249
130 Venkatraman G Mohan PS Abdul-Rahman PS Sonsudin F Muttiah B Hirad AH Alarfaj AA Wang S Morinda citrifolia leaf assisted synthesis of ZnO decorated Ag bio-nanocomposites for in-vitro cytotoxicity, antimicrobial and anticancer applications Bioprocess Biosyst Eng 47 1213 1226 2024 10.1007/s00449-024-02995-5 38509421
131 Pereira da Costa Araújo A Lima VS Emmanuela de Andrade Vieira J Mesak C Malafaia G First report on the mutagenicity and cytotoxicity of Zno nanoparticles in reptiles Chemosphere 235 556 564 2019 10.1016/j.chemosphere.2019.06.164 31276868
132 Yang D Zhang M Gan Y Yang S Wang J Yu M Wei J Chen J Involvement of oxidative stress in ZnO NPs-induced apoptosis and autophagy of mouse GC-1 spg cells Ecotoxicol Environ Saf 202 110960 2020 10.1016/j.ecoenv.2020.110960 32800232
133 Al-Zahaby SA Farag MR Alagawany M Taha HSA Varoni MV Crescenzo G Mawed SA Zinc oxide nanoparticles (ZnO-NPs) induce cytotoxicity in the zebrafish olfactory organs via activating oxidative stress and apoptosis at the ultrastructure and genetic levels Animals (Basel) 13 2867 2023 10.3390/ani13182867 37760268
134 Nazir S Rabbani A Mehmood K Maqbool F Shah GM Khan MF Sajid M Antileishmanial activity and cytotoxicity of ZnO-based nano-formulations Int J Nanomedicine 14 7809 7822 2019 10.2147/IJN.S203351 31576125
135 Czyzowska A Barbasz A Cytotoxicity of zinc oxide nanoparticles to innate and adaptive human immune cells J Appl Toxicol 41 1425 1437 2021 10.1002/jat.4133 33368402
136 Niño-Martínez N Salas Orozco MF Martínez-Castañón GA Torres Méndez F Ruiz F Molecular mechanisms of bacterial resistance to metal and metal oxide nanoparticles Int J Mol Sci 20 2808 2019 10.3390/ijms20112808 31181755
137 Alsmadi MM Al-Nemrawi NK Obaidat R Abu Alkahsi AE Korshed KM Lahlouh IK Insights into the mapping of green synthesis conditions for ZnO nanoparticles and their toxicokinetics Nanomedicine (Lond) 17 1281 1303 2022 10.2217/nnm-2022-0092 36254841
138 Marinescu L Ficai D Oprea O Marin A Ficai A Andronescu E Holban AM Optimized Synthesis approaches of metal nanoparticles with antimicrobial applications J Nanomater 2020 1 14 2020
139 Sajjad A Bhatti SH Ali Z Jaffari GH Khan NA Rizvi ZF Zia M Photoinduced fabrication of zinc oxide nanoparticles: Transformation of morphological and biological response on light irradiance ACS Omega 6 11783 11793 2021 10.1021/acsomega.1c01512 34056332
140 Al-Mosawi RM Jasim HA Haddad A Study of the antibacterial effects of the starch-based zinc oxide nanoparticles on methicillin resistance Staphylococcus aureus isolates from different clinical specimens of patients from Basrah, Iraq AIMS Microbiol 9 90 107 2023 10.3934/microbiol.2023006 36891534
141 Kim I Viswanathan K Kasi G Sadeghi K Thanakkasaranee S Seo J Preparation and characterization of positively surface charged zinc oxide nanoparticles against bacterial pathogens Microb Pathog 149 104290 2020 10.1016/j.micpath.2020.104290 32492458
142 Hozyen HF Ibrahim ES Khairy EA El-Dek SI Enhanced antibacterial activity of capped zinc oxide nanoparticles: A step towards the control of clinical bovine mastitis Vet World 12 1225 1232 2019 10.14202/vetworld.2019.1225-1232 31641301
143 Khan MF Hameedullah M Ansari AH Ahmad E Lohani MB Khan RH Alam MM Khan W Husain FM Ahmad I Flower-shaped ZnO nanoparticles synthesized by a novel approach at near-room temperatures with antibacterial and antifungal properties Int J Nanomedicine 9 853 864 2014 10.2147/IJN.S47351 24550675
144 Gharpure S Jadhav T Ghotekar C Jagtap A Vare Y Ankamwar B Non-antibacterial and antibacterial ZnO nanoparticles composed of different surfactants J Nanosci Nanotechnol 21 5945 5959 2021 10.1166/jnn.2021.19513 34229790
145 Wahab R Mishra A Yun SI Kim YS Shin HS Antibacterial activity of ZnO nanoparticles prepared via non-hydrolytic solution route Appl Microbiol Biotechnol 87 1917 1925 2010 10.1007/s00253-010-2692-2 20526594
146 Al-Askar AA Hashem AH Elhussieny NI Saied E Green biosynthesis of zinc oxide nanoparticles using Pluchea indica leaf extract: Antimicrobial and photocatalytic activities Molecules 28 4679 2023 10.3390/molecules28124679 37375234
147 Manojkumar U Kaliannan D Srinivasan V Balasubramanian B Kamyab H Mussa ZH Palaniyappan J Mesbah M Chelliapan S Palaninaicker S Green synthesis of zinc oxide nanoparticles using Brassica oleracea var. botrytis leaf extract: Photocatalytic, antimicrobial and larvicidal activity Chemosphere 323 138263 2023 10.1016/j.chemosphere.2023.138263 36858116
148 Irfan M Naz MY Saleem M Tanawush M Głowacz A Glowacz W Rahman S Mahnashi MH Alqahtani YS Alyami BA Statistical study of nonthermal plasma-assisted ZnO coating of cotton fabric through ultrasonic-assisted green synthesis for improved self-cleaning and antimicrobial properties Materials (Basel) 14 6998 2021 10.3390/ma14226998 34832398
149 Abdo AM Fouda A Eid AM Fahmy NM Elsayed AM Khalil AMA Alzahrani OM Ahmed AF Soliman AM Green synthesis of zinc oxide nanoparticles (ZnO-NPs) by Pseudomonas aeruginosa and their activity against pathogenic microbes and common house mosquito, culex pipiens Materials (Basel) 14 6983 2021 10.3390/ma14226983 34832382
